President Bola Tinubu has appointed Dr. Temitope Ilori as the new Director-General of the National Agency for the Control of AIDS (NACA).
Dr. Ilori, making history as the first female to hold the position, assumed her initial four-year term on February 22, 2024.
This announcement was made by Toyin Aderibigbe, the Head of Public Relations and Protocol at NACA, in a press statement released on Thursday.
Dr. Ilori succeeds Dr. Gambo Aliyu, who served as the DG of the agency from June 2019 until February 2024.
Prior to her appointment, Dr. Ilori served as a Senior Lecturer in the Department of Community Medicine at the University of Ibadan and as a Consultant Family Physician at the University College Hospital, Ibadan.
“Dr. Ilori obtained her MBBS degree from the University of Ibadan and completed her residency training at the University College Hospital, Ibadan, Nigeria. She graduated as the best graduating Fellow of the Faculty of Family Medicine, West African College of Physicians in April 2012, winning the A.O. Senbanjo Prize. Additionally, she is an Associate Fellow of the National Postgraduate Medical College of Nigeria.
Dr. Ilori holds a Bachelor of Science and a Master of Science Degree in Human Nutrition and Dietetics from the University of Ibadan, Nigeria. She is currently a PhD Fellow at the Department of Family Medicine and Primary Care, Faculty of Health Sciences, University of Witwatersrand, South Africa, sponsored by the Consortium for Advanced Research Training in Africa. Her research interests encompass Primary Care, Immunization, Public Health Nutrition, Non-Communicable Diseases, and Women’s and Child’s Health. She has authored or co-authored over 30 publications in peer-reviewed scientific journals.
Moreover, Dr. Ilori has been actively involved in policy formulation and strategic development. She served as the Commissioner for Health in Osun State, Nigeria, from 2011 to 2014, and held roles as Chairperson of the Osun State Agency on Control of HIV/AIDS and the Osun State Technical Working Group on Immunization,” the statement highlighted.
